Patents by Inventor Robert D. Krell

Robert D. Krell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6162464
    Abstract: Orally administered colonic purgative formulations and methods of its use for effecting partial or complete purgation of the colon in mammals, the formulations consisting of non-aqueous admixtures of a purgative salt selected from the group consisting of Mg.sub.3 (PO.sub.4).sub.2, MgHPO.sub.4, Mg(H.sub.2 PO.sub.4).sub.2, MgSO.sub.4, MgCl.sub.2, Na.sub.2 SO.sub.4, sodium tartrate, potassium tartrate, magnesium tartrate and mixtures, thereof, administered in tablet or capsule form in purgative effective concentrations. Preferred embodiments make use of at least one or more magnesium phosphate salts, more preferably dibasic magnesium phosphate; other preferred embodiments include the addition of binders, dispersants and buffers which do not adversely affect osmolality or effectiveness of the purgative formulations.
    Type: Grant
    Filed: March 31, 1997
    Date of Patent: December 19, 2000
    Assignee: Inkine Pharmaceutical, Inc.
    Inventors: Leonard S. Jacob, Taffy J. Williams, Robert D. Krell
  • Patent number: 4292305
    Abstract: Imidodisulfamide derivatives useful in the treatment of allergic conditions are prepared by reaction of an appropriately substituted primary amine and bis(chlorosulfonyl) imide in the presence of a tertiary amine.
    Type: Grant
    Filed: February 13, 1980
    Date of Patent: September 29, 1981
    Assignee: SmithKline Corporation
    Inventors: Fadia E. Ali, Robert D. Krell, Kenneth M. Snader